Varicella-zoster virus (chickenpox) infection in pregnancy
Ronald F Lamont1, Jack D Sobel, D Carrington
1Perinatology Research Branch, NICHD/NIH/DHHS, Bethesda, MD, USA. rlamont@med.wayne.edu
Summary
Preventing maternal varicella-zoster virus (VZV) infection through vaccination and outbreak control is crucial. Early VZV immunoglobulin and antiviral treatment can reduce serious fetal and newborn complications.
Area of Science:
- Obstetrics and Gynecology
- Infectious Diseases
- Pediatrics
Background:
- Varicella-zoster virus (VZV) infection during pregnancy poses significant risks.
- Congenital varicella syndrome, maternal pneumonia, and neonatal varicella can lead to severe fetomaternal morbidity and mortality.
Purpose of the Study:
- To highlight the risks associated with maternal VZV infection.
- To emphasize preventive strategies and early interventions for VZV in pregnancy.
Main Methods:
- Review of existing literature on VZV in pregnancy.
- Analysis of outcomes related to maternal VZV infection and interventions.
Main Results:
- Vaccination against VZV is effective in disease prevention.
- Outbreak control minimizes pregnant women's exposure to VZV.
- Maternal VZV immunoglobulin, with or without antivirals, can alter disease progression if given before rash onset.
Conclusions:
- Vaccination and outbreak control are key primary prevention strategies.
- Timely administration of VZV immunoglobulin and antivirals can mitigate severe outcomes.
- Protecting pregnant women from VZV is essential for reducing fetomaternal complications.
Related Concept Videos
Chickenpox
Chickenpox is an acute, highly contagious disease caused by the varicella-zoster virus (VZV), a double-stranded DNA virus belonging to the Herpesviridae family. Its transmission occurs primarily through the inhalation of respiratory droplets or direct contact with vesicular fluid from skin lesions. The incubation period typically ranges from 10 to 21 days, during which the virus replicates and disseminates through sequential phases within the host. Although generally self-limiting in children,...
Smallpox
Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.
Cytomegalovirus Disease
Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Genital Herpes
Genital herpes is a sexually transmitted infection primarily caused by herpes simplex virus type 2 (HSV-2), though herpes simplex virus type 1 (HSV-1) is increasingly implicated in genital infections, particularly among younger populations. Transmission occurs mainly through sexual contact, with asymptomatic viral shedding serving as a major route of spread. This characteristic makes HSV-2 difficult to control at a population level, as individuals may unknowingly transmit the virus even in the...
Poliomyelitis
Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...


